Y-mAbs Therapeutics (YMAB) PT Raised to $22 at Canaccord Genuity

July 25, 2023 7:06 AM EDT Send to a Friend

Canaccord Genuity analyst William Maughan ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Y-mAbs Therapeutics (YMAB) PT Raised to $22 at Canaccord Genuity

Member Login

Free News Feed